MARYNA HAYDASH: Open Payments
NPI 1447703509 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 20 payments from 13 companies in 2025. Trend: 2023 $529 · 2024 $582 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $147 |
| Phathom Pharmaceuticals, Inc. | 2 | $131 |
| ABBVIE INC. | 2 | $112 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GENZYME CORPORATION | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
Products named: AIRSUPRA, VOQUEZNA, DUPIXENT, NEFFY, Rhapsido, XHANCE, INSPIRE, Xolair.
Industry payments across WA — which companies pay providers there.
